Phase 1 (Weeks 1 to 2): 0.25 mg subcutaneous injection once daily, morning on empty stomach Phase 2 (Weeks 3 to 6): Maintain 0.25 mg or increase to 0.5 mg based on response and tolerance Phase 3 (Weeks 7 to 8): Continue or begin taper depending on symptom improvement Maintenance: Consider cycling 4 weeks on, 2 weeks off for long-term management Oral dosing requires higher amounts to compensate for bioavailability differences
That's our advice on how to use AHK-Cu - but you might find other people say that topical application isn't the only way you can harness the power of copper peptides
If you are starting at 0.25mg and the vial expires in 28 days, you face potential waste of 4mg from a single vial
Stabilization of polymeric materials
An RCT in patients receiving cisplatin chemotherapy found that NAC (1,200 mg/day) significantly reduced nephrotoxicity and ototoxicity without reducing antitumor efficacy (Riga et al., Am J Clin Oncol, 2013) [77]
Targeting ferroptosis for cancer therapy: Exploring novel strategies from its mechanisms and role in cancers